Search
Searching Content indexed under Healthcare by Katherine Wang ordered by Published Date Descending.
Links to Result pages
 
1  
 
Title
Country
Organisation
Author
Date
1
China's Central Government Introduces Major Policy Incentives And Restraints To The MedTech Industry
After continuously reshaping the competitive landscape in the pharmaceutical industry for several years, the Chinese government finally shifted its attention to the medtech industry.
China
21 Aug 2019
2
China's Health Authorities Issue New Rules on Telemedicine
The Measures clarify longstanding ambiguities regarding the scope of permitted telemedicine.
China
26 Sep 2018
3
What Companies Need To Know About China's New Market Regulator
On March 17, China's highest legislative body, the National People's Congress, approved a sweeping government restructuring plan.
China
19 Apr 2018
4
China's State Council Announces Major Policies to Reform the Pharmaceutical Industry
China will launch further reforms in the pharmaceutical sector as part of the healthcare reform initiatives announced by the State Council in its February 9, 2017 Circular on Several Opinions Concerning Further Reforms of the Policies Governing Drug Production, Circulation and Usage (the "Circular No.13").
China
20 Feb 2017
5
CFDA Solicits Comments On Drug Registration Rules
Unlike the DRR, the Revisions do not distinguish an international multicenter study from a drug registration study.
China
4 Aug 2016
6
China Liberalizes Drug Pricing Control
Beginning June 1, 2015, the vast majority drugs in China, except for narcotic and Type 1 psychotropic drugs, will be free from government-set pricing.
China
12 May 2015
7
China Announces Revised Good Clinical Practices For Public Comments
The China Food and Drug Administration recently released its proposed revisions to Good Clinical Practices ("GCP") for pharmaceutical clinical studies for public comments.
United States
16 Feb 2015
8
China Introduces New Medical Device GMP And GSP Rules
The CFDA expects all device companies to comply with the New GMP and GSP rules as long as they intend to sell the products in China.
China
8 Jan 2015
9
China’s National Auditing Office Notes Compliance Concerns With Sponsorship Of Academic Conferences In The Healthcare Sector
In China, it is common industry practice for pharmaceutical companies to sponsor academic conferences. As long as such events are aimed at enhancing the practice of medicine and patient welfare, the practice has been allowed.
United States
2 Jul 2014
10
China Releases Fast Track Approval Process For Innovative Medical Devices
On February 7, 2014, the China Food and Drug Administration promulgated a notice titled "The Fast Track Approval Process for Innovative Medical Device (Tentative)", effective as of March 1, 2014.
China
16 Feb 2014
11
China Announces Master Plan For The Healthcare Services Industry
On September 28, 2013, China’s State Council published a plan titled Opinions on Promoting the Development of the Healthcare Services Industry, which outlines policy initiatives and development goals for China’s healthcare services industry to achieve by 2020 (the "Plan").
China
17 Oct 2013
12
Chinese FDA Released Guidelines For Rx-OTC Switch
The State Food and Drug Administration recently announced a set of technical guidelines for switching prescription drugs to over-the-counter drugs.
China
5 Dec 2012
Links to Result pages
 
1